Lexington Biosciences Inc Stock Price - LXGTF

Best deals to access real time data!
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Lexington Biosciences (QB) LXGTF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.008935 -12.65% 0.0617 0.0673 0.05 0.063862 0.070635 16:15:01
Bid Price Ask Price Spread Spread % News
0.056 0.0665 0.0105 15.79% - -
Stock Trades Traded Volume Average Volume 52 Week Range
51 321,306 102.57k 0.05 - 0.48
Last Trade Time Type Quantity Stock Price Currency
15:44:01 250 $0.06 USD

Lexington Biosciences (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.34M 37.98M $ -1.99M - -1.18 36.23M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Lexington Biosciences (QB) News

Real-Time news about Lexington Biosciences (QB) (Other OTC): 0 recent articles

Latest LXGTF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXGTF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week00.067300.00000321k0--
1 Month00.067300.00000321k0--
3 Months00.067300.00000321k0--
6 Months00.067300.00000321k0--
1 Year00.067300.00000321k0--
3 Years00.067300.00000321k0--
5 Years00.067300.00000321k0--

Lexington Biosciences (QB) Description

Lexington Biosciences is a medical device company that is developing the HeartSentry, a new non-invasive diagnostic device to measure and monitor cardiovascular health by assessing the function of a person's vascular endothelium, the vital innermost lining of a person's cardiovascular system. Traditionally, this has only been measured using ultrasound and other complex, difficult to use technologies. The HeartSentry technology core research was created at the University of California Berkeley over a fifteen-year period involving many studies and product iterations resulting in a portfolio of multiple pending and issued patents licensed to the company. The company is in the final stages of releasing the developed product for clinical studies. The aim is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health. Lexington is engaged with the US FDA and other regulatory agencies on the required product approvals for the HeartSentry.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20181022 06:00:09